{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:31:55Z","timestamp":1787959915844,"version":"build-2784847793"},"reference-count":48,"publisher":"Elsevier","isbn-type":[{"value":"9780443313585","type":"print"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/bs.apha.2024.10.014","type":"book-chapter","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T18:42:25Z","timestamp":1729795345000},"page":"287-299","source":"Crossref","is-referenced-by-count":4,"title":["TL1A: A model for a precision medicine approach in the treatment of Crohn\u2019s disease and ulcerative colitis"],"prefix":"10.1016","member":"78","reference":[{"issue":"118\u2013130","key":"10.1016\/bs.apha.2024.10.014_bib1","article-title":"Crohn\u2019s disease-associated mucosal factors regulate the expression of TNF-like cytokine 1A and its receptors in primary subepithelial intestinal myofibroblasts and intestinal epithelial cells","volume":"180","author":"Bamias","year":"2017","journal-title":"Translational Research"},{"issue":"9","key":"10.1016\/bs.apha.2024.10.014_bib2","doi-asserted-by":"crossref","first-page":"4868","DOI":"10.4049\/jimmunol.171.9.4868","article-title":"Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease","volume":"171","author":"Bamias","year":"2003","journal-title":"The Journal of Immunology"},{"issue":"2","key":"10.1016\/bs.apha.2024.10.014_bib3","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ajpath.2011.10.026","article-title":"Constitutive TL1A expression under colitogenic conditions modulates the severity and location of gut mucosal inflammation and induces fibrostenosis","volume":"180","author":"Barrett","year":"2012","journal-title":"The American Journal of Pathology"},{"issue":"11","key":"10.1016\/bs.apha.2024.10.014_bib4","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1016\/j.febslet.2010.04.030","article-title":"Functional signaling of membrane-bound TL1A induces IFN-gamma expression","volume":"584","author":"Biener-Ramanujan","year":"2010","journal-title":"FEBS Letters"},{"issue":"1","key":"10.1016\/bs.apha.2024.10.014_bib5","article-title":"Divide and conquer: Using patient stratification to optimize therapeutic drug development in inflammatory bowel disease","volume":"2","author":"Bilsborough J","year":"2014","journal-title":"Journal of Immunology and Clinical Research"},{"issue":"3","key":"10.1016\/bs.apha.2024.10.014_bib6","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00018-016-2355-2","article-title":"Death receptor 3 mediates necroptotic cell death","volume":"74","author":"Bittner","year":"2017","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"2","key":"10.1016\/bs.apha.2024.10.014_bib7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/febs.13576","article-title":"Soluble TL1A is sufficient for activation of death receptor 3","volume":"283","author":"Bittner","year":"2016","journal-title":"The FEBS Journal"},{"issue":"6","key":"10.1016\/bs.apha.2024.10.014_bib8","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.immuni.2018.10.014","article-title":"Microbiota-induced TNF-like ligand 1A drives group 3 innate lymphoid cell-mediated barrier protection and intestinal T cell activation during colitis","volume":"49","author":"Castellanos","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/bs.apha.2024.10.014_bib9","doi-asserted-by":"crossref","DOI":"10.1177\/1756284819867848","article-title":"Functional rare variants influence the clinical response to anti-TNF therapy in Crohn\u2019s disease","volume":"12","author":"Chaparro","year":"2019","journal-title":"Therapeutic Advances in Gastroenterology"},{"issue":"5","key":"10.1016\/bs.apha.2024.10.014_bib10","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1084\/jem.20072528","article-title":"Essential role of TNF receptor superfamily 25 (TNFRSF25) in the development of allergic lung inflammation","volume":"205","author":"Fang","year":"2008","journal-title":"Journal of Experimental Medicine"},{"issue":"Suppl. 1","key":"10.1016\/bs.apha.2024.10.014_bib11","doi-asserted-by":"crossref","first-page":"i162","DOI":"10.1093\/ecco-jcc\/jjac190.0127","article-title":"DOP87 the anti-TL1A antibody PRA023 demonstrated proof-of-concept in Crohn\u2019s disease: Phase 2a APOLLO-CD study results","volume":"17","author":"Feagan","year":"2023","journal-title":"Journal of Crohn\u2019s and Colitis"},{"issue":"9","key":"10.1016\/bs.apha.2024.10.014_bib12","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.4049\/jimmunol.2000665","article-title":"TL1A promotes lung tissue fibrosis and airway remodeling","volume":"205","author":"Herro","year":"2020","journal-title":"The Journal of Immunology"},{"issue":"3","key":"10.1016\/bs.apha.2024.10.014_bib13","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/MIB.0b013e31828075e7","article-title":"Association study of 71 European Crohn\u2019s disease susceptibility loci in a Japanese population","volume":"19","author":"Hirano","year":"2013","journal-title":"Inflammatory Bowel Disease"},{"key":"10.1016\/bs.apha.2024.10.014_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-75168-5","article-title":"Direct signaling of TL1A-DR3 on fibroblasts induces intestinal fibrosis in vivo","volume":"10","author":"Jacob","year":"2020","journal-title":"Scientific Reports"},{"issue":"7422","key":"10.1016\/bs.apha.2024.10.014_bib15","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nature11582","article-title":"Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease","volume":"491","author":"Jostins","year":"2012","journal-title":"Nature"},{"issue":"9","key":"10.1016\/bs.apha.2024.10.014_bib16","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/ng.3359","article-title":"Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations","volume":"47","author":"Liu","year":"2015","journal-title":"Nature Genetics"},{"issue":"34","key":"10.1016\/bs.apha.2024.10.014_bib17","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2120771120","article-title":"Tumor necrosis factor\u2013like cytokine 1A plays a role in inflammatory bowel disease pathogenesis","volume":"120","author":"Meng","year":"2023","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"2","key":"10.1016\/bs.apha.2024.10.014_bib18","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/mi.2010.67","article-title":"The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation","volume":"4","author":"Meylan","year":"2011","journal-title":"Mucosal Immunology"},{"issue":"3","key":"10.1016\/bs.apha.2024.10.014_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004719","article-title":"IBD-associated TL1A gene (TNFSF15) haplotypes determine increased expression of TL1A protein","volume":"4","author":"Michelsen","year":"2009","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/bs.apha.2024.10.014_bib20","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S1074-7613(02)00283-2","article-title":"TL1A is a TNF-like ligand for DR3 and TR6\/DcR3 and functions as a T cell costimulator","volume":"16","author":"Migone","year":"2002","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/bs.apha.2024.10.014_bib21","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1093\/gerona\/glq129","article-title":"Two functionally distinct isoforms of TL1A (TNFSF15) generated by differential ectodomain shedding","volume":"65","author":"M\u00fcck","year":"2010","journal-title":"Journals of Gerontology\u2014Series A Biological Sciences and Medical Sciences"},{"issue":"2","key":"10.1016\/bs.apha.2024.10.014_bib22","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1053\/gast.2001.27154","article-title":"CCR9-positive lymphocytes and thymus-expressed chemokine distinguish small bowel from colonic Crohn\u2019s disease","volume":"121","author":"Papadakis","year":"2001","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/bs.apha.2024.10.014_bib23","doi-asserted-by":"crossref","first-page":"7002","DOI":"10.4049\/jimmunol.172.11.7002","article-title":"TL1A synergizes with IL-12 and IL-18 to enhance IFN-gamma production in human T cells and NK cells","volume":"172","author":"Papadakis","year":"2004","journal-title":"The Journal of Immunology"},{"issue":"8","key":"10.1016\/bs.apha.2024.10.014_bib24","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.4049\/jimmunol.174.8.4985","article-title":"Dominant role for TL1A\/DR3 pathway in IL-12 plus IL-18-induced IFN-gamma production by peripheral blood and mucosal CCR9+ T lymphocytes","volume":"174","author":"Papadakis","year":"2005","journal-title":"The Journal of Immunology"},{"issue":"5","key":"10.1016\/bs.apha.2024.10.014_bib25","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1084\/jem.20071364","article-title":"TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease","volume":"205","author":"Pappu","year":"2008","journal-title":"Journal of Experimental Medicine"},{"issue":"1","key":"10.1016\/bs.apha.2024.10.014_bib26","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.clim.2004.02.007","article-title":"Potential role for TL1A, the new TNF-family member and potent costimulator of IFN-gamma, in mucosal inflammation","volume":"112","author":"Prehn","year":"2004","journal-title":"Clinical Immunology"},{"issue":"7","key":"10.1016\/bs.apha.2024.10.014_bib27","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.4049\/jimmunol.178.7.4033","article-title":"The T cell costimulator TL1A is induced by FcgammaR signaling in human monocytes and dendritic cells","volume":"178","author":"Prehn","year":"2007","journal-title":"The Journal of Immunology"},{"issue":"Suppl. 1","key":"10.1016\/bs.apha.2024.10.014_bib28","doi-asserted-by":"crossref","first-page":"i56","DOI":"10.1093\/ecco-jcc\/jjac190.0040","article-title":"OP40 PRA023 demonstrated efficacy and favorable safety as induction therapy for moderately to severely active UC: Phase 2 ARTEMIS-UC study results","volume":"17","author":"Sands","year":"2023","journal-title":"Journal of Crohn\u2019s and Colitis"},{"issue":"10","key":"10.1016\/bs.apha.2024.10.014_bib29","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/apt.16605","article-title":"Loss of response to anti-TNF\u03b1 agents depends on treatment duration in patients with inflammatory bowel disease","volume":"54","author":"Schultheiss","year":"2021","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"1","key":"10.1016\/bs.apha.2024.10.014_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016090","article-title":"Constitutive TL1A (TNFSF15) expression on lymphoid or myeloid cells leads to mild intestinal inflammation and fibrosis","volume":"6","author":"Shih","year":"2011","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/bs.apha.2024.10.014_bib31","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1002\/eji.200839087","article-title":"Microbial induction of inflammatory bowel disease associated gene TL1A (TNFSF15) in antigen presenting cells","volume":"39","author":"Shih","year":"2009","journal-title":"European Journal of Immunology"},{"issue":"6","key":"10.1016\/bs.apha.2024.10.014_bib32","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1038\/mi.2014.37","article-title":"Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosis","volume":"7","author":"Shih","year":"2014","journal-title":"Mucosal Immunology"},{"issue":"3","key":"10.1016\/bs.apha.2024.10.014_bib33","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/MIB.0000000000000653","article-title":"Differential levels of Tl1a affect the expansion and function of regulatory T cells in modulating murine colitis","volume":"22","author":"Sidhu-Varma","year":"2016","journal-title":"Inflammatory Bowel Disease"},{"issue":"2","key":"10.1016\/bs.apha.2024.10.014_bib34","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1053\/j.gastro.2008.04.037","article-title":"TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation","volume":"135","author":"Takedatsu","year":"2008","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/bs.apha.2024.10.014_bib35","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1053\/j.gastro.2008.04.037","article-title":"TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T helper (TH) 1 and TH17 activation","volume":"135","author":"Takedatsu","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/bs.apha.2024.10.014_bib36","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3389\/fimmu.2019.00583","article-title":"TL1A (TNFSF15) and DR3 (TNFRSF25): A co-stimulatory system of cytokines with diverse functions in gut mucosal immunity","volume":"10","author":"Valatas","year":"2019","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.apha.2024.10.014_bib37","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/1471-2369-15-178","article-title":"TL1-A can engage death receptor-3 and activate NF-kappa B in endothelial cells","volume":"15","author":"Wang","year":"2014","journal-title":"BMC Nephrology"},{"issue":"8","key":"10.1016\/bs.apha.2024.10.014_bib38","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/ecco-jcc\/jjz017","article-title":"Novel genetic risk variants can predict anti-TNF agent response in patients with inflammatory bowel disease","volume":"13","author":"Wang","year":"2019","journal-title":"Journal of Crohn\u2019s and Colitis"},{"issue":"11","key":"10.1016\/bs.apha.2024.10.014_bib39","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.4049\/jimmunol.1301475","article-title":"TNF-like ligand 1A (TL1A) gene knockout leads to ameliorated collagen-induced arthritis in mice: Implication of TL1A in humoral immune responses","volume":"191","author":"Wang","year":"2013","journal-title":"The Journal of Immunology"},{"key":"10.1016\/bs.apha.2024.10.014_bib40","doi-asserted-by":"crossref","first-page":"5927064","DOI":"10.1155\/2021\/5927064","article-title":"Effect and mechanism of TL1A expression on epithelial-mesenchymal transition during chronic colitis-related intestinal fibrosis","volume":"2021","author":"Wenxiu","year":"2021","journal-title":"Mediators Inflamm"},{"key":"10.1016\/bs.apha.2024.10.014_bib41","article-title":"Role of TL1A in inflammatory autoimmune diseases: A comprehensive review","volume":"13","author":"Xu","year":"2022","journal-title":"Frontiers in Immunology"},{"issue":"22","key":"10.1016\/bs.apha.2024.10.014_bib42","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1093\/hmg\/ddi379","article-title":"Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn\u2019s disease","volume":"14","author":"Yamazaki","year":"2005","journal-title":"Human Molecular Genetics"},{"issue":"10","key":"10.1016\/bs.apha.2024.10.014_bib43","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.crohns.2014.04.002","article-title":"TNFSF15 is an independent predictor for the development of Crohn\u2019s disease-related complications in Koreans","volume":"8","author":"Yang","year":"2014","journal-title":"Journal of Crohn\u2019s and Colitis"},{"key":"10.1016\/bs.apha.2024.10.014_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102337","article-title":"Comparative effectiveness of ustekinumab vs. vedolizumab for anti-TNF-na\u00efve or anti-TNF-exposed Crohn\u2019s disease: A multicenter cohort study","volume":"66","author":"Yang","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"8","key":"10.1016\/bs.apha.2024.10.014_bib45","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1097\/MIB.0000000000001150","article-title":"Colonic phenotypes are associated with poorer response to anti-TNF therapies in patients with IBD","volume":"23","author":"Yoon","year":"2017","journal-title":"Inflammatory Bowel Disease"},{"issue":"3","key":"10.1016\/bs.apha.2024.10.014_bib46","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/mi.2013.92","article-title":"TNF superfamily member TL1A elicits type 2 innate lymphoid cells at mucosal barriers","volume":"7","author":"Yu","year":"2014","journal-title":"Mucosal Immunology"},{"issue":"8","key":"10.1016\/bs.apha.2024.10.014_bib47","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3109\/08916934.2014.930735","article-title":"Associations between TNFSF15 polymorphisms and susceptibility to ulcerative colitis and Crohn\u2019s disease: A meta-analysis","volume":"47","author":"Zhang","year":"2014","journal-title":"Autoimmunity"},{"issue":"10","key":"10.1016\/bs.apha.2024.10.014_bib48","doi-asserted-by":"crossref","DOI":"10.1177\/0300060520961675","article-title":"Polymorphism rs6478109 in the TNFSF15 gene contributes to the susceptibility to Crohn\u2019s disease but not ulcerative colitis: A meta-analysis","volume":"48","author":"Zhou","year":"2020","journal-title":"Journal of International Medical Research"}],"container-title":["Advances in Pharmacology","Emerging Therapeutic Targets and Drug Delivery Approaches in IBD"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358924000437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358924000437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T17:56:03Z","timestamp":1753293363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1054358924000437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9780443313585"],"references-count":48,"URL":"https:\/\/doi.org\/10.1016\/bs.apha.2024.10.014","relation":{},"ISSN":["1054-3589"],"issn-type":[{"value":"1054-3589","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]}}}